SARS CoV 2 News and Research

RSS

New methods can advance the development of rapid diagnostics for many infectious diseases

Two companion studies report new artificial intelligence approaches for identification of molecular "fingerprints" for specific infections. The methods, used here to derive a fingerprint for COVID-19, can advance the development of rapid diagnostics for many infectious diseases.

21 Dec 2022

Dutch study shows the effectiveness of COVID vaccination in reducing hospitalizations

The study, which is currently available in the medRxiv* preprint server, reveals that the COVID-19 vaccination has prevented a large number of hospitalizations during the pandemic.

21 Dec 2022

History of COVID-19 increases risk of fatigue and other long COVID symptoms in adults and children

Researchers observe that COVID-19 patients were at an increased risk of developing certain conditions.

21 Dec 2022

Brazilian model for COVID-19 vaccination reduced severe case and mortality even from variants

A study conducted in Serrana, a small town in São Paulo state used as a model for COVID-19 vaccination in Brazil, shows that mass vaccination reduced the severe case and death rates even while the gamma and delta variants were circulating.

21 Dec 2022

Study: Long COVID has four major subtypes defined by different clusters of symptoms

The post-COVID syndrome known as long COVID has four major subtypes defined by different clusters of symptoms, according to a study led by researchers at Weill Cornell Medicine.

21 Dec 2022

WHO releases a global strategy for infection prevention and control at the 75th World Health Assembly

A recent draft released by the World Health Organization discussed the new global strategy to address the gaps in infection prevention and control (IPC) programs that became apparent after the coronavirus disease 2019 (COVID-19) pandemic.

21 Dec 2022

SARS-CoV-2 and human cold coronavirus OC43 inhibit stress granule formation through Nsp15 protein

Researchers investigated the mechanisms through which the human common cold Betacoronavirus OC43 (HCoV-OC43) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibit the formation of stress granules.

21 Dec 2022

What are the long-term outcomes of critical COVID-19 patients?

Researchers assessed the long-term outcomes of critically ill coronavirus disease 2019 (COVID-19) patients.

21 Dec 2022

Review on nanoparticles usage for treating thrombosis induced by SARS-CoV-2 infections

Researchers provided an overview of nanomedicine strategies to treat coronavirus disease 2019 (COVID-19)-induced thrombosis.

21 Dec 2022

Age-stratified analysis of COVID-19 severity outcomes among vaccinees and individuals with prior SARS-CoV-2 exposure in Indiana

Researchers assessed the effectiveness of vaccine-conferred immune protection against novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, any-cause visits to hospitals and emergency departments (ED), and deaths in Indiana.

21 Dec 2022

Exploring environmental viral emissions after SARS-CoV-2 Human challenge

A recent study captured the dynamics of pre-symptomatic SARS-CoV-2 emissions and reported the extent, magnitude, and routes of viral transmission are heterogeneous, with nasal mucosa being an important source of viral transmission.

21 Dec 2022

SILVER Study provides insight into the challenges presented by COVID-19 to older New Yorkers

ICAP at Columbia University Mailman School of Public Health has released results from Round Two of the SILVER Study, providing insight into the challenges presented by COVID-19 to older adults living at home in New York City.

20 Dec 2022

Findings on the origins of the SARS-CoV-2 variant Omicron retracted

On December 1, Charité – Universitätsmedizin Berlin reported new findings on the origins of the SARS-CoV-2 variant Omicron.

20 Dec 2022

Study examines the association of dementia diagnosis with risk of COVID-19 mortality

Since December 2019, more than 60 million people have been diagnosed with coronavirus disease 2019 (COVID-19) worldwide, while approximately six million individuals have died as a result of the disease.

20 Dec 2022

Study finds increased risk of POTS after SARS-CoV-2 infection or COVID vaccination

Researchers report the frequencies of novel POTS-related diagnoses prior to and after SARS-CoV-2 infection and COVID-19 vaccination.

20 Dec 2022

Can ivermectin improve the duration of sustained recovery among COVID-19 outpatients?

Researchers assessed the impact of ivermectin on the duration of sustained recovery among coronavirus disease 2019 (COVID-19) outpatients.

20 Dec 2022

Withdrawal of COVID-19 mitigation measures resulted in a rebound in Streptococcus pneumoniae cases in Germany

Researchers from Germany conducted a population-based surveillance study to ascertain the etiology of community acquired pneumonia (CAP) during the re-emergence of viral and bacterial respiratory diseases after the relaxation of coronavirus disease 2019 (COVID-19) containment and mitigation measures.

20 Dec 2022

SARS CoV 2 News and Research

New methods can advance the development of rapid diagnostics for many infectious diseases

Dutch study shows the effectiveness of COVID vaccination in reducing hospitalizations

History of COVID-19 increases risk of fatigue and other long COVID symptoms in adults and children

Brazilian model for COVID-19 vaccination reduced severe case and mortality even from variants

Study: Long COVID has four major subtypes defined by different clusters of symptoms

WHO releases a global strategy for infection prevention and control at the 75th World Health Assembly

SARS-CoV-2 and human cold coronavirus OC43 inhibit stress granule formation through Nsp15 protein

What are the long-term outcomes of critical COVID-19 patients?

Review on nanoparticles usage for treating thrombosis induced by SARS-CoV-2 infections

Age-stratified analysis of COVID-19 severity outcomes among vaccinees and individuals with prior SARS-CoV-2 exposure in Indiana

Exploring environmental viral emissions after SARS-CoV-2 Human challenge

SILVER Study provides insight into the challenges presented by COVID-19 to older New Yorkers

Findings on the origins of the SARS-CoV-2 variant Omicron retracted

Study examines the association of dementia diagnosis with risk of COVID-19 mortality

Study finds increased risk of POTS after SARS-CoV-2 infection or COVID vaccination

Can ivermectin improve the duration of sustained recovery among COVID-19 outpatients?

Withdrawal of COVID-19 mitigation measures resulted in a rebound in Streptococcus pneumoniae cases in Germany

COVID-19 epidemiology can be estimated using blood donation samples

Study finds several flavor/fragrance compositions that inhibit vRBD-hACE2 binding

The potential effects of receiving 2 SARS-CoV-2 vaccine doses on household transmission in England

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News